Amedeo Smart

Free Medical Literature Service

 

Amedeo

Arrhythmias
  Free Subscription

Articles published in
Eur Heart J
    April 2024

  1. Correction to: XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation.
    Eur Heart J. 2024 Apr 17:ehae227. doi: 10.1093.
    >> Share

  2. CHEN Q, van Rein N, van der Hulle T, Heemelaar JC, et al
    Coexisting atrial fibrillation and cancer: time trends and associations with mortality in a nationwide Dutch study.
    Eur Heart J. 2024 Apr 15:ehae222. doi: 10.1093.
    >> Share

  3. TEPPO K, Airaksinen KEJ, Jaakkola J, Halminen O, et al
    Ischaemic stroke in women with atrial fibrillation: temporal trends and clinical implications.
    Eur Heart J. 2024 Apr 12:ehae198. doi: 10.1093.
    >> Share

  4. PALUDAN-MULLER C, Vad OB, Stampe NK, Diederichsen SZ, et al
    Atrial fibrillation: age at diagnosis, incident cardiovascular events, and mortality.
    Eur Heart J. 2024 Apr 9:ehae216. doi: 10.1093.
    >> Share

  5. LIP GYH, Nikorowitsch J, Sehner S, Becher N, et al
    Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial.
    Eur Heart J. 2024 Apr 9:ehae225. doi: 10.1093.
    >> Share

  6. CREA F
    The complex interaction between cancer, ischaemic heart disease, and heart failure, and a focus on arrhythmias including risk stratification in Brugada syndrome and leadless pacing.
    Eur Heart J. 2024;45:1183-1187.
    >> Share

  7. GAITA F, Cerrato N, Giustetto C
    Can an implantable loop recorder improve risk stratification and appropriate management in Brugada syndrome?
    Eur Heart J. 2024;45:1266-1268.
    >> Share

  8. BERGONTI M, Sacher F, Arbelo E, Crotti L, et al
    Implantable loop recorders in patients with Brugada syndrome: the BruLoop study.
    Eur Heart J. 2024;45:1255-1265.
    >> Share

  9. EL-CHAMI MF, Garweg C, Clementy N, Al-Samadi F, et al
    Leadless pacemakers at 5-year follow-up: the Micra transcatheter pacing system post-approval registry.
    Eur Heart J. 2024;45:1241-1251.
    >> Share

  10. LIUZZO G, Pedicino D
    Weekly journal scan: the KCa2 potassium channel as a promising target for the pharmacologic cardioversion of atrial fibrillation.
    Eur Heart J. 2024 Apr 1:ehae138. doi: 10.1093.
    >> Share

    March 2024
  11. CREA F
    Challenges in arrhythmias: anticoagulation in asymptomatic atrial fibrillation, stellate ganglion block in electrical storm, and ECG for prediction of sudden death.
    Eur Heart J. 2024;45:739-743.
    >> Share

  12. ZURIAGA MA, Pascual-Figal D, Fuster JJ
    Clonal haematopoiesis and cardiac arrythmias: rhythm-altering mutations.
    Eur Heart J. 2024;45:806-808.
    >> Share

  13. SAVASTANO S, Baldi E, Compagnoni S, Rordorf R, et al
    Electrical storm treatment by percutaneous stellate ganglion block: the STAR study.
    Eur Heart J. 2024;45:823-833.
    >> Share

  14. FIALHO GL
    Epilepsy and the heart: can 'brain arrhythmia' lead to cardiac arrhythmias? Back to the basics.
    Eur Heart J. 2024;45:853-854.
    >> Share

  15. PHAM HN, Holmstrom L, Chugh H, Uy-Evanado A, et al
    Dynamic electrocardiogram changes are a novel risk marker for sudden cardiac death.
    Eur Heart J. 2024;45:809-819.
    >> Share

  16. SCHUERMANS A, Vlasschaert C, Nauffal V, Cho SMJ, et al
    Clonal haematopoiesis of indeterminate potential predicts incident cardiac arrhythmias.
    Eur Heart J. 2024;45:791-805.
    >> Share

  17. SUN Y, Zhou Y, Yu B, Zhang K, et al
    Frailty, genetic predisposition, and incident atrial fibrillation.
    Eur Heart J. 2024 Mar 5:ehae130. doi: 10.1093.
    >> Share

  18. SUDO K, Nakamura K, Sato A
    Usefulness of endomyocardial biopsy using three-dimensional delivery system for the diagnosis of cardiac amyloidosis with complete atrioventricular block after transcatheter aortic valve implantation.
    Eur Heart J. 2024 Mar 5:ehae137. doi: 10.1093.
    >> Share

  19. MURARU D, Badano LP, Hahn RT, Lang RM, et al
    Atrial secondary tricuspid regurgitation: pathophysiology, definition, diagnosis, and treatment.
    Eur Heart J. 2024 Mar 5:ehae088. doi: 10.1093.
    >> Share

    February 2024
  20. SVENNBERG E, Diederichsen SZ
    Anticoagulation in device-detected atrial fibrillation: a long journey to find the sweet spot.
    Eur Heart J. 2024 Feb 21:ehae044. doi: 10.1093.
    >> Share

  21. CREA F
    Anticoagulation in atrial fibrillation and implantable cardioverter defibrillator implantation in arrhythmogenic right ventricular cardiomyopathy: need for improving patient selection.
    Eur Heart J. 2024;45:491-494.
    >> Share

  22. MALIK V, Shivkumar K
    Stellate ganglion blockade for the management of ventricular arrhythmia storm.
    Eur Heart J. 2024 Feb 15:ehae083. doi: 10.1093.
    >> Share

  23. HOLT A, Nouhravesh N, Strange JE, Kinnberg Nielsen S, et al
    Cannabis for chronic pain: cardiovascular safety in a nationwide Danish study.
    Eur Heart J. 2024;45:475-484.
    >> Share

  24. ZURKAN D, Pitt B, Edelmann F
    Mineralocorticoid receptor antagonists for the prevention of atrial fibrillation in patients with and without heart failure: one more beneficial effect?
    Eur Heart J. 2024 Feb 6:ehae040. doi: 10.1093.
    >> Share

  25. LIUZZO G, Patrono C
    Edoxaban for atrial high-rate episodes: more harm than good?
    Eur Heart J. 2024;45:330-331.
    >> Share

    January 2024
  26. ELLIOTT PM
    Transatlantic differences in the use of implantable cardioverter defibrillators in arrhythmogenic right ventricular cardiomyopathy.
    Eur Heart J. 2024 Jan 30:ehae022. doi: 10.1093.
    >> Share

  27. YOUNES H, Rao S, Marrouche N
    Deciphering connections: how is cryoablation interlinking with disease progression in atrial fibrillation ablation?
    Eur Heart J. 2024 Jan 24:ehad872. doi: 10.1093.
    >> Share

  28. BRIENESSE S, Passman R, Freedman B
    Interruption of oral anticoagulants after atrial fibrillation catheter ablation: the importance of risk stratification.
    Eur Heart J. 2024 Jan 23:ehad874. doi: 10.1093.
    >> Share

  29. DEHARO P, Obadia JF, Guerin P, Cuisset T, et al
    Mitral transcatheter edge to edge repair versus isolated mitral surgery for severe mitral regurgitation: A French nationwide study.
    Eur Heart J. 2024 Jan 19:ehae046. doi: 10.1093.
    >> Share

  30. VERGALLO R, Galiuto L
    Targeting inflammation with colchicine does not prevent atrial fibrillation after major non-cardiac thoracic surgery.
    Eur Heart J. 2024 Jan 18:ehae006. doi: 10.1093.
    >> Share

  31. AHN HJ, An HY, Ryu G, Lim J, et al
    Clonal haematopoiesis of indeterminate potential and atrial fibrillation: an east Asian cohort study.
    Eur Heart J. 2024 Jan 17:ehad869. doi: 10.1093.
    >> Share

  32. SAMARAS A, Papazoglou AS, Balomenakis C, Bekiaridou A, et al
    Residual leaks following percutaneous left atrial appendage occlusion and outcomes: a meta-analysis.
    Eur Heart J. 2024;45:214-229.
    >> Share

  33. ORAII A, Healey JS, Kowalik K, Pandey AK, et al
    Mineralocorticoid receptor antagonists and atrial fibrillation: a meta-analysis of clinical trials.
    Eur Heart J. 2024 Jan 9:ehad811. doi: 10.1093.
    >> Share

  34. CARRICK RT, De Marco C, Gasperetti A, Bosman LP, et al
    Implantable cardioverter defibrillator use in arrhythmogenic right ventricular cardiomyopathy in North America and Europe.
    Eur Heart J. 2024 Jan 9:ehad799. doi: 10.1093.
    >> Share

  35. LIUZZO G, Patrono C
    Balancing the benefits and risks of anticoagulation in patients with subclinical atrial fibrillation.
    Eur Heart J. 2024 Jan 8:ehad859. doi: 10.1093.
    >> Share

  36. CREA F
    The key role of thrombosis: focus on acute coronary syndrome, venous thrombo-embolism, and atrial fibrillation.
    Eur Heart J. 2024;45:1-4.
    >> Share

  37. PIESZKO K, Hiczkiewicz J, Lojewska K, Uzieblo-Zyczkowska B, et al
    Artificial intelligence in detecting left atrial appendage thrombus by transthoracic echocardiography and clinical features: the Left Atrial Thrombus on Transoesophageal Echocardiography (LATTEE) registry.
    Eur Heart J. 2024;45:32-41.
    >> Share

    December 2023
  38. PROVIDENCIA R, Kukendra-Rajah K, Barra S
    Amiodarone for atrial fibrillation: a dead man walking?
    Eur Heart J. 2023 Dec 29:ehad825. doi: 10.1093.
    >> Share

  39. KRAMARENKO D, Walsh R
    Emery-Dreifuss muscular dystrophy: a closer look at cardiac complications.
    Eur Heart J. 2023;44:5074-5076.
    >> Share

  40. KANAOKA K, Nishida T, Iwanaga Y, Nakai M, et al
    Oral anticoagulation after atrial fibrillation catheter ablation: benefits and risks.
    Eur Heart J. 2023 Dec 20:ehad798. doi: 10.1093.
    >> Share

  41. HATALA R, Hlivak P
    Atrial fibrillation in chronic coronary syndromes: a neglected challenge.
    Eur Heart J. 2023 Dec 17:ehad781. doi: 10.1093.
    >> Share

    November 2023
  42. SPOSATO LA, Lip GYH, Haeusler KG
    Atrial fibrillation first detected after stroke: is timing and detection intensity relevant for stroke risk?
    Eur Heart J. 2023 Nov 28:ehad744. doi: 10.1093.
    >> Share

  43. ANJUM M, Ariansen I, Hjellvik V, Selmer R, et al
    Stroke and bleeding risk in atrial fibrillation with CHA2DS2-VASC risk score of one: the Norwegian AFNOR study.
    Eur Heart J. 2023 Nov 23:ehad659. doi: 10.1093.
    >> Share

  44. MARCHLINSKI FE, Oraii A, Muser D
    Anticoagulation for atrial fibrillation in patients with intermediate stroke risk: is the grey zone becoming less grey?
    Eur Heart J. 2023 Nov 23:ehad751. doi: 10.1093.
    >> Share

  45. BECHER N, Toennis T, Bertaglia E, Blomstrom-Lundqvist C, et al
    Anticoagulation with edoxaban in patients with long Atrial High-Rate Episodes >/=24 hours.
    Eur Heart J. 2023 Nov 12:ehad771. doi: 10.1093.
    >> Share

  46. TSABAN G, Ostrovsky D, Alnsasra H, Burrack N, et al
    Amiodarone and pulmonary toxicity in atrial fibrillation: a nationwide Israeli study.
    Eur Heart J. 2023 Nov 6:ehad726. doi: 10.1093.
    >> Share

  47. DEMIDOVA MM, Holmqvist F, Erlinge D, Platonov PG, et al
    Ventricular arrhythmias during ST-segment elevation myocardial infarction and arrhythmic complications during recurrent ischaemic events.
    Eur Heart J. 2023 Nov 3:ehad740. doi: 10.1093.
    >> Share

  48. INCIARDI RM, Solomon SD
    Beyond the rhythm: atrial fibrillation, diastolic dysfunction, and heart failure.
    Eur Heart J. 2023 Nov 3:ehad747. doi: 10.1093.
    >> Share

    October 2023
  49. ELLIOTT AD, Benjamin EJ, Middeldorp ME
    Prevention of atrial fibrillation: a call to action.
    Eur Heart J. 2023 Oct 31:ehad738. doi: 10.1093.
    >> Share

  50. TILZ RR, Heeger CH
    Be aware and hit hard and early: oesophageal lesions after atrial fibrillation ablation.
    Eur Heart J. 2023 Oct 26:ehad692. doi: 10.1093.
    >> Share

  51. SCANAVACCA M, Pisani C, Rivarola EWR
    Early identification of oesophageal lesions after atrial fibrillation ablation to prevent atrio-oesophageal fistula.
    Eur Heart J. 2023 Oct 26:ehad689. doi: 10.1093.
    >> Share

  52. CREA F
    Innovative trials in heart failure, dyslipidaemias, and sinus node dysfunction.
    Eur Heart J. 2023;44:4203-4207.
    >> Share

  53. PEDICINO D, Volpe M
    Atrial fibrillation ablation improves outcomes in patients with end-stage heart failure: is it all gold the glitter in the CASTLE?
    Eur Heart J. 2023 Oct 17:ehad675. doi: 10.1093.
    >> Share

  54. MARX N, Federici M, Schutt K, Muller-Wieland D, et al
    2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes.
    Eur Heart J. 2023;44:4043-4140.
    >> Share

  55. APOSTOLOS A, Aggeli C, Toutouzas K
    Nickel hypersensitivity as the cause of atrial fibrillation after patent foramen ovale closure: fact or myth?
    Eur Heart J. 2023 Oct 4:ehad643. doi: 10.1093.
    >> Share

  56. PAPIOL E, Pastor P, Pueo E
    Skin lesions, weight loss, and ventricular tachycardia: connecting the dots to diagnose multisystemic sarcoidosis.
    Eur Heart J. 2023;44:3705.
    >> Share

    September 2023
  57. LI E, Yan C, Yang X
    Long QT syndrome induced by cervical spondylosis.
    Eur Heart J. 2023 Sep 22:ehad608. doi: 10.1093.
    >> Share

  58. CREA F
    Challenges and opportunities in prognostication: focus on ischaemic heart disease and atrial fibrillation.
    Eur Heart J. 2023;44:3391-3394.
    >> Share

  59. TANAKA Y, Kuroki K, Kaga S
    Life-threatening left atrioesophageal fistula complicated with catheter ablation for atrial fibrillation in a patient with aortic stent graft.
    Eur Heart J. 2023 Sep 19:ehad609. doi: 10.1093.
    >> Share

  60. WANG N, Yu Y, Sun Y, Zhang H, et al
    Acquired risk factors and incident atrial fibrillation according to age and genetic predisposition.
    Eur Heart J. 2023 Sep 19:ehad615. doi: 10.1093.
    >> Share

  61. CREA F
    Focus on atrial fibrillation in specific clinical settings and on calmodulinopathy.
    Eur Heart J. 2023;44:3299-3302.
    >> Share

  62. WANG J, Huang P, Yu Q, Lu J, et al
    Epilepsy and long-term risk of arrhythmias.
    Eur Heart J. 2023;44:3374-3382.
    >> Share

  63. BARSHESHET A, Goldenberg I
    Advancing personalized medicine: the power of collaborative registries of patients with inherited cardiac arrhythmia syndromes.
    Eur Heart J. 2023;44:3371-3373.
    >> Share

  64. CROTTI L, Spazzolini C, Nyegaard M, Overgaard MT, et al
    Clinical presentation of calmodulin mutations: the International Calmodulinopathy Registry.
    Eur Heart J. 2023;44:3357-3370.
    >> Share

  65. MOHANTY S, La Fazia VM, Natale A
    The Antwerp score: is this the 'new hope on the horizon'?
    Eur Heart J. 2023;44:3336-3338.
    >> Share

  66. GONG X, Liu JX, Huang XB
    Surgical removal of acoustic neuroma eliminates sick sinus syndrome.
    Eur Heart J. 2023;44:3388.
    >> Share

  67. COURT-KOWALSKI S, McArthur A, Hayres K
    Pulsus paradoxus, electrical alternans, and pulsus alternans in progressive cardiac tamponade.
    Eur Heart J. 2023;44:3297.
    >> Share

  68. MIDDELDORP ME, Sandhu RK
    The stroke enigma: decoding the sex risk factor in atrial fibrillation.
    Eur Heart J. 2023 Sep 6:ehad531. doi: 10.1093.
    >> Share

    August 2023
  69. BUHARI H, Fang J, Han L, Austin PC, et al
    Stroke risk in women with atrial fibrillation.
    Eur Heart J. 2023 Aug 30:ehad508. doi: 10.1093.
    >> Share

  70. CANNIE DE, Syrris P, Protonotarios A, Bakalakos A, et al
    Emery-Dreifuss Muscular Dystrophy 1 is associated with high risk of malignant ventricular arrhythmias and end-stage heart failure.
    Eur Heart J. 2023 Aug 28:ehad561. doi: 10.1093.
    >> Share

  71. NASER JA, Lee E, Scott CG, Kennedy AM, et al
    Prevalence and Incidence of Diastolic Dysfunction in Atrial Fibrillation: Clinical Implications.
    Eur Heart J. 2023 Aug 28:ehad592. doi: 10.1093.
    >> Share

  72. PARKASH R
    Atrial pacing and atrial fibrillation in sinus node dysfunction: a relationship that remains elusive.
    Eur Heart J. 2023 Aug 28:ehad569. doi: 10.1093.
    >> Share

  73. KRONBORG MB, Frausing MHJP, Malczynski J, Riahi S, et al
    Atrial pacing minimization in sinus node dysfunction and risk of incident atrial fibrillation: a randomized trial.
    Eur Heart J. 2023 Aug 28:ehad564. doi: 10.1093.
    >> Share

  74. GAUTIER A, Picard F, Ducrocq G, Elbez Y, et al
    New-onset atrial fibrillation in chronic coronary syndrome: the CLARIFY registry.
    Eur Heart J. 2023 Aug 27:ehad556. doi: 10.1093.
    >> Share

  75. ANDRADE JG, Deyell MW, Khairy P, Champagne J, et al
    Atrial fibrillation progression after cryoablation versus radiofrequency ablation: the CIRCA-DOSE trial.
    Eur Heart J. 2023 Aug 25:ehad572. doi: 10.1093.
    >> Share

  76. MEYRE PB, Conen D
    Adverse outcomes in patients with atrial fibrillation: how previous successes can unmask new challenges.
    Eur Heart J. 2023 Aug 25:ehad575. doi: 10.1093.
    >> Share

  77. WU J, Nadarajah R, Nakao YM, Nakao K, et al
    Temporal trends of cause-specific mortality after diagnosis of atrial fibrillation.
    Eur Heart J. 2023 Aug 25:ehad571. doi: 10.1093.
    >> Share

  78. VERRIER RL, Pang TD, Schachter SC
    Long-term risk for atrial and ventricular arrhythmias: a cardinal manifestation of 'the epileptic heart'.
    Eur Heart J. 2023 Aug 22:ehad524. doi: 10.1093.
    >> Share

  79. KAWAKAMI R, Finn AV, Virmani R
    Histopathology of atrial fibrillation: does this help us understand its pathogenesis?
    Eur Heart J. 2023 Aug 17:ehad515. doi: 10.1093.
    >> Share

  80. OZKAN J
    Barbara Casadei receives award for outstanding research into atrial fibrillation.
    Eur Heart J. 2023 Aug 16:ehad495. doi: 10.1093.
    >> Share

  81. ESSAYAGH B, Sabbag A, El-Am E, Cavalcante JL, et al
    Arrhythmic mitral valve prolapse and mitral annular disjunction: pathophysiology, risk stratification, and management.
    Eur Heart J. 2023 Aug 10:ehad491. doi: 10.1093.
    >> Share

    July 2023
  82. CAMM AJ
    Should the risk of atrial fibrillation deter PFO closure for cryptogenic ischaemic stroke?
    Eur Heart J. 2023 Jul 21:ehad425. doi: 10.1093.
    >> Share

  83. CREA F
    Addressing the pandemic of atrial fibrillation: optimization of catheter ablation and new therapeutic targets.
    Eur Heart J. 2023;44:2413-2416.
    >> Share

  84. WILDE AAM, Amin AS, Morita H, Tadros R, et al
    Use, misuse, and pitfalls of the drug challenge test in the diagnosis of the Brugada syndrome.
    Eur Heart J. 2023;44:2427-2439.
    >> Share

  85. SUDO K, Kuroki K, Sato A
    Dynamical improvement after rescue balloon angioplasty for pulmonary vein occlusion complicated with radiofrequency catheter ablation.
    Eur Heart J. 2023;44:2498.
    >> Share

  86. MARCUS GM
    Translating HARMS2-AF into benefits for our atrial fibrillation patients and the general public: challenges and opportunities.
    Eur Heart J. 2023 Jul 5:ehad423. doi: 10.1093.
    >> Share

  87. PEDICINO D, Volpe M
    Coffee drinking and cardiac ectopic beats: Black or White?
    Eur Heart J. 2023;44:2275-2276.
    >> Share

    June 2023
  88. BERGONTI M, Ascione C, Marcon L, Pambrun T, et al
    Left ventricular functional recovery after atrial fibrillation catheter ablation in heart failure: a prediction model.
    Eur Heart J. 2023 Jun 30:ehad428. doi: 10.1093.
    >> Share

  89. DOUGHERTY S, Nascimento B, Okello E
    Oral anticoagulation for atrial fibrillation in rheumatic heart disease.
    Eur Heart J. 2023 Jun 29:ehad390. doi: 10.1093.
    >> Share

  90. TAKAHASHI Y, Yamaguchi T, Otsubo T, Nakashima K, et al
    Histological validation of atrial structural remodelling in patients with atrial fibrillation.
    Eur Heart J. 2023 Jun 23:ehad396. doi: 10.1093.
    >> Share

  91. SEGAN L, Canovas R, Nanayakkara S, Chieng D, et al
    New-onset atrial fibrillation prediction: the HARMS2-AF risk score.
    Eur Heart J. 2023 Jun 23:ehad375. doi: 10.1093.
    >> Share

  92. METZNER A, Kirchhof P
    Good rhythm control without haste: atrial fibrillation ablation remains effective after a year of waiting.
    Eur Heart J. 2023 Jun 22:ehad393. doi: 10.1093.
    >> Share

  93. LIM MW, Kalman JM
    Putting fear into perspective: estimating the true incidence of oesophageal fistula formation post-atrial fibrillation ablation.
    Eur Heart J. 2023 Jun 8:ehad309. doi: 10.1093.
    >> Share

  94. SKIBSTED CV, Korsholm K, Pedersen L, Bonnesen K, et al
    Long-term risk of atrial fibrillation or flutter after transcatheter patent foramen ovale closure: a nationwide Danish study.
    Eur Heart J. 2023 Jun 3:ehad305. doi: 10.1093.
    >> Share

    May 2023
  95. LEHTONEN J, Uusitalo V, Poyhonen P, Mayranpaa MI, et al
    Cardiac sarcoidosis: phenotypes, diagnosis, treatment, and prognosis.
    Eur Heart J. 2023;44:1495-1510.
    >> Share

    April 2023
  96. LEE J, Kim JS, Shim CY
    MitraClip single-leaflet detachment and consequent migration in atrial functional mitral regurgitation.
    Eur Heart J. 2023 Apr 26:ehad249. doi: 10.1093.
    >> Share

  97. TILZ RR, Schmidt V, Purerfellner H, Maury P, et al
    A worldwide survey on incidence, management and prognosis of oesophageal fistula formation following atrial fibrillation catheter ablation: The POTTER-AF study.
    Eur Heart J. 2023 Apr 16:ehad250. doi: 10.1093.
    >> Share

  98. KALMAN JM, Al-Kaisey AM, Parameswaran R, Hawson J, et al
    Impact of Early Versus Delayed Atrial Fibrillation Catheter Ablation on Atrial Arrhythmia Recurrences.
    Eur Heart J. 2023 Apr 16:ehad247. doi: 10.1093.
    >> Share

  99. HAEUSLER KG
    Ischaemic stroke in atrial fibrillation patients while on oral anticoagulation-a call for A-C-T-I-O-N.
    Eur Heart J. 2023 Apr 11:ehad203. doi: 10.1093.
    >> Share

  100. BENZ AP, Hohnloser SH, Eikelboom JW, Carnicelli AP, et al
    Outcomes of patients with atrial fibrillation and ischemic stroke while on oral anticoagulation.
    Eur Heart J. 2023 Apr 11:ehad200. doi: 10.1093.
    >> Share

  101. RENNISON JH, Van Wagoner DR
    Dysregulated Ca2+ cycling in atrial fibrillation.
    Eur Heart J. 2023 Apr 4:ehad099. doi: 10.1093.
    >> Share

    March 2023
  102. FRIMODT-MOLLER EK, Soliman EZ, Kizer JR, Vittinghoff E, et al
    Lifestyle habits associated with cardiac conduction disease.
    Eur Heart J. 2023;44:1058-1066.
    >> Share

  103. NOUBIAP JJ, Middeldorp ME
    Prevention of cardiac conduction disease: a long way to go.
    Eur Heart J. 2023;44:1067-1069.
    >> Share

  104. THIELE H, Desch S, Freund A
    Out-of-hospital cardiac arrest without ST-segment elevation: an alternative focus on priorities?
    Eur Heart J. 2023;44:1055-1057.
    >> Share

  105. CREA F
    Cardiovascular diseases in pregnancy, congenital heart disease, and arrhythmias: lessons from epidemiology.
    Eur Heart J. 2023;44:699-702.
    >> Share

  106. AL-KAISEY AM, Kalman JM
    Atrial arrhythmia recurrence post-catheter ablation: when perfect is the enemy of good.
    Eur Heart J. 2023;44:777-779.
    >> Share

    February 2023
  107. GRAMMATIKA PAVLIDOU N, Dobrev S, Beneke K, Reinhardt F, et al
    Phosphodiesterase 8 governs cAMP/PKA-dependent reduction of L-type calcium current in human atrial fibrillation: a novel arrhythmogenic mechanism.
    Eur Heart J. 2023 Feb 22:ehad086. doi: 10.1093.
    >> Share

  108. LIU X, Luo H, Qin X
    Vanishing 'table tennis': a case of active left atrial thrombus.
    Eur Heart J. 2023;44:698.
    >> Share

  109. WOUTERS PC, van de Leur RR, Vessies MB, van Stipdonk AMW, et al
    Electrocardiogram-based deep learning improves outcome prediction following cardiac resynchronization therapy.
    Eur Heart J. 2023;44:680-692.
    >> Share

  110. LAMBIASE PD, Sanders P, Crijns HJGM
    The year in cardiovascular medicine 2022: the top 10 papers in arrhythmias.
    Eur Heart J. 2023;44:345-347.
    >> Share

    January 2023
  111. GAUDINO M, Di Franco A, Rong LQ, Piccini J, et al
    Postoperative atrial fibrillation: from mechanisms to treatment.
    Eur Heart J. 2023 Jan 31:ehad019. doi: 10.1093.
    >> Share

  112. BUTCHER SC, Essayagh B, Steyerberg EW, Benfari G, et al
    Factors influencing post-surgical survival in degenerative mitral regurgitation.
    Eur Heart J. 2023 Jan 26:ehad004. doi: 10.1093.
    >> Share


  113. Corrigendum to: Investigator-reported ventricular arrhythmias and mortality in heart failure with mildly reduced or preserved ejection fraction.
    Eur Heart J. 2023 Jan 24:ehad045. doi: 10.1093.
    >> Share

  114. KANAMURA T, Hashimoto T, Shiose A, Tsutsui H, et al
    Thrombus associated with locked-in atrial fibrillation in recipient remnant left atrium after heart transplantation.
    Eur Heart J. 2023 Jan 20:ehad008. doi: 10.1093.
    >> Share

  115. NARDUCCI ML, Pedicino D
    A new defibrillation strategy for refractory ventricular fibrillation during out-of-hospital cardiac arrest: are two better than one?
    Eur Heart J. 2023 Jan 20:ehad002. doi: 10.1093.
    >> Share

  116. WALDMANN V, Barra S, Marijon E
    Ventricular arrhythmias and sudden cardiac death in heart failure with mildly reduced or preserved ejection fraction: knowledge gaps.
    Eur Heart J. 2023 Jan 20:ehad001. doi: 10.1093.
    >> Share

  117. CREA F
    Management of atrial fibrillation: role of population screening, biomarkers, and polygenic risk scores.
    Eur Heart J. 2023;44:167-170.
    >> Share

  118. CURTAIN JP, Adamson C, Kondo T, Butt J, et al
    Investigator-reported ventricular arrhythmias and mortality in heart failure with mildly reduced or preserved ejection fraction.
    Eur Heart J. 2023 Jan 12:ehac801. doi: 10.1093.
    >> Share

  119. ACHA MR, Glikson M
    Type 2 diabetes mellitus association with atrioventricular block.
    Eur Heart J. 2023 Jan 7:ehac755. doi: 10.1093.
    >> Share

    December 2022
  120. LIUZZO G, Patrono C
    Vitamin K antagonists remain the INVICTUS standard of care for patients with rheumatic heart disease and atrial fibrillation.
    Eur Heart J. 2022 Dec 17:ehac721. doi: 10.1093.
    >> Share

  121. MATUSIK PS, Matusik PT, Stein PK
    Heart rate variability and heart rate patterns measured from wearable and implanted devices in screening for atrial fibrillation: potential clinical and population-wide applications.
    Eur Heart J. 2022 Dec 17:ehac546. doi: 10.1093.
    >> Share

  122. CREA F
    Novel risk factors for atrial fibrillation, conduction disturbances, sudden coronary death, and device infection.
    Eur Heart J. 2022;43:4853-4857.
    >> Share

  123. LAZZERINI PE, Boutjdir M, Capecchi PL
    Anti-Ro/SSA-antibodies and heart rhythm disturbances in the general population: the 'dark side of the immune'.
    Eur Heart J. 2022;43:4920-4922.
    >> Share

  124. AKUKA A, Ben-Shabat N, Watad A, Tsur AM, et al
    Association of anti-Ro seropositivity with cardiac rhythm and conduction disturbances.
    Eur Heart J. 2022;43:4912-4919.
    >> Share

  125. TFELT-HANSEN J, Winkel BG, de Riva M, Zeppenfeld K, et al
    The '10 commandments' for the 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death.
    Eur Heart J. 2022 Dec 7:ehac699. doi: 10.1093.
    >> Share

  126. O'SULLIVAN JW, Ashley EA, Elliott PM
    Polygenic risk scores for the prediction of cardiometabolic disease.
    Eur Heart J. 2022 Dec 7:ehac648. doi: 10.1093.
    >> Share

  127. ANDREOTTI F, Geisler T, Collet JP, Gigante B, et al
    Acute, periprocedural and longterm antithrombotic therapy in older adults.
    Eur Heart J. 2022 Dec 7:ehac515. doi: 10.1093.
    >> Share

  128. ANDRADE JG, Deyell MW, Macle L, Steinberg JS, et al
    Healthcare utilization and quality of life for atrial fibrillation burden: the CIRCA-DOSE study.
    Eur Heart J. 2022 Dec 2:ehac692. doi: 10.1093.
    >> Share

  129. SPATZ ES, Herrin J
    Screening for atrial fibrillation to prevent stroke: increasing enthusiasm but outcomes still lag.
    Eur Heart J. 2022 Dec 2:ehac696. doi: 10.1093.
    >> Share

  130. OSMANCIK P, Widimsky P
    Left atrial appendage occluders-new hope for stroke prevention in high-risk patients.
    Eur Heart J. 2022;43:4669-4671.
    >> Share

    November 2022
  131. HAXHA S, Halili A, Malmborg M, Pedersen-Bjergaard U, et al
    Type 2 diabetes mellitus and higher rate of complete atrioventricular block: a Danish Nationwide Registry.
    Eur Heart J. 2022 Nov 26:ehac662. doi: 10.1093.
    >> Share

  132. KU L, Chen Y, Ma X
    Pericardial-esophageal fistula caused by radiofrequency ablation for atrial fibrillation.
    Eur Heart J. 2022 Nov 22:ehac673. doi: 10.1093.
    >> Share

  133. SINNER MF, von Falkenhausen AS
    A specific new biomarker for atrial fibrillation and its sequelae?
    Eur Heart J. 2022 Nov 18. pii: 6833208. doi: 10.1093.
    >> Share

  134. GOLDENBERG L, Huang DT
    Subcutaneous implantable cardioverter defibrillator for the prevention of sudden cardiac death: ready for prime-time?
    Eur Heart J. 2022 Nov 16. pii: 6830653. doi: 10.1093.
    >> Share

  135. HIJAZI Z, Benz AP, Lindback J, Alexander JH, et al
    Bone morphogenetic protein 10: a novel risk marker of ischaemic stroke in patients with atrial fibrillation.
    Eur Heart J. 2022 Nov 16. pii: 6830621. doi: 10.1093.
    >> Share

  136. HARRINGTON J, Granger CB
    Bleeding and risk for future cardiovascular events in patients with atrial fibrillation on oral anticoagulation: major bleeding is a major problem.
    Eur Heart J. 2022 Nov 16. pii: 6830575. doi: 10.1093.
    >> Share

  137. HOLMSTROM L, Chugh SS
    How to minimize in-hospital mortality from acute myocardial infarction: focus on primary prevention of ventricular fibrillation.
    Eur Heart J. 2022 Nov 15. pii: 6827956. doi: 10.1093.
    >> Share

  138. LYTH J, Svennberg E, Bernfort L, Aronsson M, et al
    Cost-effectiveness of population screening for atrial fibrillation: the STROKESTOP study.
    Eur Heart J. 2022 Nov 9. pii: 6806218. doi: 10.1093.
    >> Share

    October 2022
  139. GARCIA R, Marijon E, Karam N, Narayanan K, et al
    Ventricular fibrillation in acute myocardial infarction: 20-year trends in the FAST-MI study.
    Eur Heart J. 2022 Oct 28. pii: 6776117. doi: 10.1093.
    >> Share

  140. MEYRE PB, Blum S, Hennings E, Aeschbacher S, et al
    Bleeding and ischaemic events after first bleed in anticoagulated atrial fibrillation patients: risk and timing.
    Eur Heart J. 2022 Oct 26. pii: 6773770. doi: 10.1093.
    >> Share

  141. GAWALKO M, Sanders P
    Drug abuse and risk of atrial fibrillation: a neglected association.
    Eur Heart J. 2022 Oct 26. pii: 6774408. doi: 10.1093.
    >> Share

  142. YANG Y, Xie L, Qian H, Cui K, et al
    Minimally invasive videoscope-assisted cardiac surgery for paroxysmal atrial tachycardia originating from right atrial appendage.
    Eur Heart J. 2022 Oct 26. pii: 6774389. doi: 10.1093.
    >> Share

  143. KAAB S, Holm H, Kirchhof P
    Genomic risk scores, biomolecules, and clinical conditions to predict atrial fibrillation: time to integrate what we can measure.
    Eur Heart J. 2022 Oct 21. pii: 6767860. doi: 10.1093.
    >> Share

  144. CREA F
    New tools to predict and new therapeutic targets to treat life-threatening ventricular arrhythmias.
    Eur Heart J. 2022;43:3983-3986.
    >> Share

  145. BRIGNOLE M, Sutton R
    Left bundle branch area pacing in perspective.
    Eur Heart J. 2022;43:4174-4176.
    >> Share

  146. LINZ D, McIntyre WF
    Sinus rhythm: the sine qua non for rhythm control?
    Eur Heart J. 2022;43:4145-4147.
    >> Share

  147. JASTRZEBSKI M, Kielbasa G, Cano O, Curila K, et al
    Left bundle branch area pacing outcomes: the multicentre European MELOS study.
    Eur Heart J. 2022;43:4161-4173.
    >> Share

  148. VANDEWIELE F, Pironet A, Jacobs G, Kecskes M, et al
    TRPM4 inhibition by meclofenamate suppresses Ca2+-dependent triggered arrhythmias.
    Eur Heart J. 2022;43:4195-4207.
    >> Share

  149. HEIJMAN J, Dobrev D
    Molecular determinants and therapeutic potential of focal ectopic activity: more than meets the Iti.
    Eur Heart J. 2022;43:4208-4210.
    >> Share

  150. TORBATI T, Shufelt C, Wei J, Noel Bairey Merz C, et al
    Premature menopause and cardiovascular disease: can we blame estrogen?
    Eur Heart J. 2022;43:4158-4160.
    >> Share

  151. MONDA E, Lioncino M, Limongelli G
    Sudden cardiac death risk prediction in arrhythmogenic right ventricular cardiomyopathy: the challenge of complex statistical modelling and its impact in clinical practice.
    Eur Heart J. 2022 Oct 20. pii: 6763998. doi: 10.1093.
    >> Share

  152. CADRIN-TOURIGNY J, Bosman LP, James CA
    Sudden cardiac death risk prediction in arrhythmogenic right ventricular cardiomyopathy: a practical approach to navigating the challenges of prediction models.
    Eur Heart J. 2022 Oct 20. pii: 6764102. doi: 10.1093.
    >> Share

  153. LIN AL, Nah G, Tang JJ, Vittinghoff E, et al
    Cannabis, cocaine, methamphetamine, and opiates increase the risk of incident atrial fibrillation.
    Eur Heart J. 2022 Oct 18. pii: 6754793. doi: 10.1093.
    >> Share

  154. LI J
    Long QT syndrome: long story short.
    Eur Heart J. 2022 Oct 18. pii: 6762505. doi: 10.1093.
    >> Share

  155. XIAO Q, Pu X, Wei X, Chen M, et al
    Refractory cardiogenic shock in a senile atrial fibrillation patient after left atrial appendage occlusion.
    Eur Heart J. 2022 Oct 17. pii: 6761762. doi: 10.1093.
    >> Share

    September 2022
  156. NABETA T, Kitai T, Naruse Y, Taniguchi T, et al
    Risk stratification of patients with cardiac sarcoidosis: the ILLUMINATE-CS registry.
    Eur Heart J. 2022;43:3450-3459.
    >> Share

  157. MA S, Jiang J
    Pulmonary vein stenosis stenting in a patient with persistent left superior vena cava after atrial fibrillation ablation.
    Eur Heart J. 2022 Sep 16. pii: 6701795. doi: 10.1093.
    >> Share


  158. Corrigendum to: Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week.
    Eur Heart J. 2022 Sep 15. pii: 6701590. doi: 10.1093.
    >> Share

  159. KOVACS B, Mayinger M, Andratschke N, Saguner AM, et al
    Stereotactic arrhythmia radioablation: competitor or adjunct to catheter ablation?
    Eur Heart J. 2022;43:3279-3281.
    >> Share

    August 2022
  160. SMEDSRUD MK, Chivulescu M, Forsa MI, Castrini I, et al
    Highly malignant disease in childhood-onset arrhythmogenic right ventricular cardiomyopathy.
    Eur Heart J. 2022 Aug 29. pii: 6676380. doi: 10.1093.
    >> Share

  161. ECKARDT L, Sehner S, Suling A, Borof K, et al
    Attaining sinus rhythm mediates improved outcome with early rhythm control therapy of atrial fibrillation: the EAST - AFNET 4 trial.
    Eur Heart J. 2022 Aug 29. pii: 6675568. doi: 10.1093.
    >> Share

  162. KONDO T, Abdul-Rahim AH, Talebi A, Abraham WT, et al
    Predicting stroke in heart failure and reduced ejection fraction without atrial fibrillation.
    Eur Heart J. 2022 Aug 26. pii: 6676501. doi: 10.1093.
    >> Share

  163. ZEPPENFELD K, Tfelt-Hansen J, de Riva M, Winkel BG, et al
    2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death.
    Eur Heart J. 2022 Aug 26. pii: 6675633. doi: 10.1093.
    >> Share

  164. SAGRIS D, Shantsila E, Lip GYH
    Stroke risk stratification in patients with heart failure and sinus rhythm.
    Eur Heart J. 2022 Aug 26. pii: 6676507. doi: 10.1093.
    >> Share

  165. CHEN Q, Sen B, Feng X, Yang Q, et al
    Catastrophic atrial tachycardia-induced cardiomyopathy in a teenager treated by extracorporeal membrane oxygenation and stereotactic arrhythmia radioablation.
    Eur Heart J. 2022;43:3086.
    >> Share

  166. CORRADO D, Link MS, Schwartz PJ
    Implantable defibrillators in primary prevention of genetic arrhythmias. A shocking choice?
    Eur Heart J. 2022;43:3029-3040.
    >> Share

  167. GRONDIN S, Davies B, Cadrin-Tourigny J, Steinberg C, et al
    Importance of genetic testing in unexplained cardiac arrest.
    Eur Heart J. 2022;43:3071-3081.
    >> Share

  168. HUQI A, Zoccali C, Giugliano RP, De Caterina R, et al
    Safety of non-vitamin K antagonist oral anticoagulants: concerns in patients with atrial fibrillation and glomerular hyperfiltration?
    Eur Heart J. 2022 Aug 19. pii: 6671685. doi: 10.1093.
    >> Share

  169. MARSTON NA, Garfinkel AC, Kamanu FK, Melloni GM, et al
    A polygenic risk score predicts atrial fibrillation in cardiovascular disease.
    Eur Heart J. 2022 Aug 18. pii: 6671409. doi: 10.1093.
    >> Share

  170. NARDUCCI ML, Volpe M
    Atrial fibrosis detected by cardiac magnetic resonance in persistent atrial fibrillation: a useful risk stratifier but not ideal electrophysiological endpoint for catheter ablation.
    Eur Heart J. 2022 Aug 8. pii: 6658237. doi: 10.1093.
    >> Share


  171. Corrigendum to: Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator.
    Eur Heart J. 2022 Aug 5. pii: 6656112. doi: 10.1093.
    >> Share

  172. DE CATERINA R, Agewall S, Andreotti F, Angiolillo DJ, et al
    Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week.
    Eur Heart J. 2022 Aug 4. pii: 6655770. doi: 10.1093.
    >> Share

  173. SHIN J, Han K, Jung JH, Park HJ, et al
    Age at menopause and risk of heart failure and atrial fibrillation: a nationwide cohort study.
    Eur Heart J. 2022 Aug 4. pii: 6646730. doi: 10.1093.
    >> Share

    July 2022
  174. KHAIRY P
    Sudden cardiac death in adults with transposition of the great arteries and systemic right ventricles: preventing (night)MAREs.
    Eur Heart J. 2022;43:2695-2697.
    >> Share

  175. BRIDA M, Chessa M, Celermajer D, Li W, et al
    Atrial septal defect in adulthood: a new paradigm for congenital heart disease.
    Eur Heart J. 2022;43:2660-2671.
    >> Share


  176. Corrigendum to: Cardiac sympathetic denervation in the prevention of genetically mediated life-threatening ventricular arrhythmias.
    Eur Heart J. 2022 Jul 8. pii: 6633850. doi: 10.1093.
    >> Share

  177. LIP GYH, Lane DA, Lenarczyk R, Boriani G, et al
    Integrated care for optimizing the management of stroke and associated heart disease: a position paper of the European Society of Cardiology Council on Stroke.
    Eur Heart J. 2022;43:2442-2460.
    >> Share

    June 2022
  178. PROTONOTARIOS A, Bariani R, Cappelletto C, Pavlou M, et al
    Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator.
    Eur Heart J. 2022 Jun 29. pii: 6619317. doi: 10.1093.
    >> Share

  179. JORDA P, Bosman LP, Gasperetti A, Mazzanti A, et al
    Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator.
    Eur Heart J. 2022 Jun 29. pii: 6619318. doi: 10.1093.
    >> Share

  180. GANDJBAKHCH E, Vischer AS
    Arrhythmogenic right ventricular cardiomyopathy: the never-ending quest for a risk calculator.
    Eur Heart J. 2022 Jun 29. pii: 6619319. doi: 10.1093.
    >> Share

  181. GOYAL P, Kim M, Krishnan U, Mccullough SA, et al
    Post-operative atrial fibrillation and risk of heart failure hospitalization.
    Eur Heart J. 2022 Jun 28. pii: 6617280. doi: 10.1093.
    >> Share

  182. MIDDELDORP ME, Albert CM
    Post-operative AF and heart failure hospitalizations: what remains hidden in patients undergoing surgery.
    Eur Heart J. 2022 Jun 28. pii: 6617281. doi: 10.1093.
    >> Share

  183. NINNI S, Longere B, Mirabel X
    Stereotactic radioablation to treat ventricular tachycardia related to a left ventricular mass.
    Eur Heart J. 2022;43:2341.
    >> Share


  184. Erratum to: Influence of atrial fibrillation on efficacy and safety of omecamtiv mecarbil in heart failure: the GALACTIC-HF trial.
    Eur Heart J. 2022 Jun 18. pii: 6610027. doi: 10.1093.
    >> Share

  185. WEI X, Zhou M, Chen Y, Chen M, et al
    Paroxysmal massive mitral regurgitation.
    Eur Heart J. 2022 Jun 17. pii: 6609956. doi: 10.1093.
    >> Share

  186. CREA F
    The complex link among heart failure, atrial fibrillation, and lung diseases, and an update on cardiac transplantation.
    Eur Heart J. 2022;43:2165-2169.
    >> Share

  187. LADOUCEUR M, Van De Bruaene A, Kauling R, Budts W, et al
    A new score for life-threatening ventricular arrhythmias and sudden cardiac death in adults with transposition of the great arteries and a systemic right ventricle.
    Eur Heart J. 2022 Jun 8. pii: 6604048. doi: 10.1093.
    >> Share

  188. CACHEUX M, Akar FG
    A novel exosome-based therapy for post-MI arrhythmias.
    Eur Heart J. 2022;43:2157-2159.
    >> Share

  189. BRIGNOLE M, Soranna D, Rienstra M
    Is APAF-CRT robust enough to change clinical practice?
    Eur Heart J. 2022;43:2161-2162.
    >> Share

  190. PABEL S, Sossalla S
    Atrial fibrillation and heart failure: novel insights into the chicken and egg dilemma.
    Eur Heart J. 2022 Jun 2. pii: 6599046. doi: 10.1093.
    >> Share

    May 2022
  191. JOHNSEN SP, Proietti M, Maggioni AP, Lip GYH, et al
    A multinational European network to implement integrated care in elderly multimorbid atrial fibrillation patients: the AFFIRMO Consortium.
    Eur Heart J. 2022 May 22. pii: 6590386. doi: 10.1093.
    >> Share

  192. VAN VELDHUISEN SL, Gorter TM, van Woerden G, de Boer RA, et al
    Bariatric surgery and cardiovascular disease: a systematic review and meta-analysis.
    Eur Heart J. 2022;43:1955-1969.
    >> Share

  193. REMME CA, Leclercq C, Behr ER
    The European Cardiac Arrhythmia Genetics (ECGen) Focus Group.
    Eur Heart J. 2022;43:1891-1894.
    >> Share

  194. LIUZZO G, Patrono C
    A novel inhibitor of Factor XIa as potential haemostasis-sparing anticoagulant for patients with atrial fibrillation.
    Eur Heart J. 2022 May 13. pii: 6585115. doi: 10.1093.
    >> Share

  195. KANY S, Metzner A, Lubos E, Kirchhof P, et al
    The Atrial Fibrillation Heart Team-guiding therapy in left atrial appendage occlusion with increasingly complex patients and little evidence.
    Eur Heart J. 2022;43:1691-1692.
    >> Share

  196. CARRION-SANCHEZ I, Cobos-Gil MA
    Electrical alternans detected by an Apple Watch.
    Eur Heart J. 2022;43:1775.
    >> Share

    April 2022
  197. ODENING KE, van der Linde HJ, Ackerman MJ, Volders PGA, et al
    Electromechanical reciprocity and arrhythmogenesis in long-QT syndrome and beyond.
    Eur Heart J. 2022 Apr 21. pii: 6571781. doi: 10.1093.
    >> Share


  198. Corrigendum to: A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy.
    Eur Heart J. 2022 Apr 20. pii: 6569859. doi: 10.1093.
    >> Share

  199. VAN DER MEER P, Rienstra M, van Veldhuisen DJ
    A deleterious interaction between omecamtiv mecarbil and atrial fibrillation in patients with heart failure: an influence of digoxin?
    Eur Heart J. 2022 Apr 20. pii: 6571185. doi: 10.1093.
    >> Share

  200. CADRIN-TOURIGNY J, Bosman LP, Nozza A, Wang W, et al
    A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy.
    Eur Heart J. 2022 Apr 20. pii: 6569858. doi: 10.1093.
    >> Share

  201. HONG S, Kim KS, Han K, Park CY, et al
    Acromegaly and cardiovascular outcomes: a cohort study.
    Eur Heart J. 2022;43:1491-1499.
    >> Share

  202. STIEGLIS R, Zijlstra JA, Riedijk F, Smeekes M, et al
    Alert system-supported lay defibrillation and basic life-support for cardiac arrest at home.
    Eur Heart J. 2022;43:1465-1474.
    >> Share

  203. FERNANDEZ ASENSIO R, Pascual Calleja I, Moris de la Tassa C, Colunga Blanco S, et al
    Pneumopericardium mimicking ST-segment elevation acute coronary syndrome.
    Eur Heart J. 2022;43:1516.
    >> Share

    March 2022
  204. SANDHU A, Varosy PD
    Left atrial appendage occlusion in patients unable to tolerate anticoagulation is cost-effective in Sweden: but how generalizable is this finding?
    Eur Heart J. 2022;43:1357-1359.
    >> Share

  205. SOLOMON SD, Claggett BL, Miao ZM, Diaz R, et al
    Influence of atrial fibrillation on efficacy and safety of omecamtiv mecarbil in heart failure: the GALACTIC-HF trial.
    Eur Heart J. 2022 Mar 23. pii: 6552734. doi: 10.1093.
    >> Share

  206. CREA F
    Novel mechanistic insights into ventricular arrhythmias and sudden death.
    Eur Heart J. 2022;43:1177-1180.
    >> Share

  207. CRIJNS HJGM, Sanders P, Albert CM, Lambiase PD, et al
    The year in cardiovascular medicine 2021: arrhythmias.
    Eur Heart J. 2022;43:1191-1197.
    >> Share

  208. CASTILHO BM, Domingues K, Damasio AF
    Pacemaker malcapture and wide QRS complexes.
    Eur Heart J. 2022;43:1272.
    >> Share

  209. SCHWARTZ PJ, Ackerman MJ
    Cardiac sympathetic denervation in the prevention of genetically mediated life-threatening ventricular arrhythmias.
    Eur Heart J. 2022 Mar 18. pii: 6550339. doi: 10.1093.
    >> Share

  210. SLATER NR, Murphy KR, Sikkel MB
    VT storm in long QT resulting from COVID-19 vaccine allergy treated with epinephrine.
    Eur Heart J. 2022;43:1176.
    >> Share

  211. MCINTYRE WF, Linz D
    Atrial fibrillation and stroke: who is low risk and what are we going to do about it?
    Eur Heart J. 2022 Mar 10. pii: 6546014. doi: 10.1093.
    >> Share

  212. KOMEN JJ, Pottegard A, Mantel-Teeuwisse AK, Forslund T, et al
    Oral anticoagulants in patients with atrial fibrillation at low stroke risk: a multicentre observational study.
    Eur Heart J. 2022 Mar 10. pii: 6546013. doi: 10.1093.
    >> Share

  213. PRINZEN FW, Auricchio A, Mullens W, Linde C, et al
    Electrical management of heart failure: from pathophysiology to treatment.
    Eur Heart J. 2022 Mar 10. pii: 6546052. doi: 10.1093.
    >> Share

  214. DAWKINS JF, Ehdaie A, Rogers R, Soetkamp D, et al
    Biological substrate modification suppresses ventricular arrhythmias in a porcine model of chronic ischaemic cardiomyopathy.
    Eur Heart J. 2022 Mar 9. pii: 6545456. doi: 10.1093.
    >> Share

  215. MEHILLI J, Winhard M
    The CHADS-P2A2RC score: ready to guide the selection of treatment?
    Eur Heart J. 2022;43:1005-1007.
    >> Share

  216. NASSER R, Meyten N, Vermeersch P, Prihadi EA, et al
    When the solution becomes the problem: left atrial appendage occlusion device-related thrombus after 5 years.
    Eur Heart J. 2022;43:1015.
    >> Share

    February 2022
  217. KAUR H, McIntyre WF, Belley-Cote EP
    Ablate and pace for patients with atrial fibrillation: a fragile option?
    Eur Heart J. 2022 Feb 21. pii: 6533261. doi: 10.1093.
    >> Share

  218. JARED BUNCH T, Steinberg BA
    Clinical strokes in atrial fibrillation: the tip of the iceberg.
    Eur Heart J. 2022 Feb 18. pii: 6532261. doi: 10.1093.
    >> Share

  219. KUHNE M, Krisai P, Coslovsky M, Rodondi N, et al
    Silent brain infarcts impact on cognitive function in atrial fibrillation.
    Eur Heart J. 2022 Feb 17. pii: 6529516. doi: 10.1093.
    >> Share

  220. MUTAGAYWA RK, Chin A, Karaye K, Bonny A, et al
    Unmet needs in the management of arrhythmias among heart failure patients in Africa.
    Eur Heart J. 2022 Feb 15. pii: 6528559. doi: 10.1093.
    >> Share

  221. TAGGART P, Nash MP, Lambiase P
    Ventricular fibrillation: combined myocardial substrate and Purkinje ablation.
    Eur Heart J. 2022 Feb 9. pii: 6525334. doi: 10.1093.
    >> Share

  222. HAISSAGUERRE M, Cheniti G, Hocini M, Sacher F, et al
    Purkinje network and myocardial substrate at the onset of human ventricular fibrillation: implications for catheter ablation.
    Eur Heart J. 2022 Feb 3. pii: 6521660. doi: 10.1093.
    >> Share

    January 2022
  223. CREA F
    Cardio-oncology: a focus on cardiovascular toxicities of cancer therapies and on atrial fibrillation in cancer.
    Eur Heart J. 2022;43:245-248.
    >> Share

  224. NARDUCCI ML, Volpe M
    Implantable recorders and systematic atrial fibrillation detection do not outperform standard of care in stroke prevention in the LOOP study.
    Eur Heart J. 2022;43:261-262.
    >> Share

  225. NOUBIAP JJ
    The association of atrial fibrillation with mortality in patients with breast cancer.
    Eur Heart J. 2022 Jan 28. pii: 6516864. doi: 10.1093.
    >> Share

  226. LAMBIASE PD, Theuns DA, Murgatroyd F, Barr C, et al
    Subcutaneous implantable cardioverter-defibrillators: long-term results of the EFFORTLESS study.
    Eur Heart J. 2022 Jan 28. pii: 6516831. doi: 10.1093.
    >> Share

  227. GUHA A, Alonso A, Addison D
    The association of atrial fibrillation with mortality in patients with breast cancer: author reply.
    Eur Heart J. 2022 Jan 28. pii: 6516863. doi: 10.1093.
    >> Share

  228. BENFARI G, Sorajja P, Pedrazzini G, Taramasso M, et al
    Association of transcatheter edge-to-edge repair with improved survival in older patients with severe, symptomatic degenerative mitral regurgitation.
    Eur Heart J. 2022 Jan 28. pii: 6516827. doi: 10.1093.
    >> Share

  229. NICHOLLS M
    Preventing stroke in atrial fibrillation patients.
    Eur Heart J. 2022 Jan 25. pii: 6515302. doi: 10.1093.
    >> Share


  230. Corrigendum to: Incidence, Risk Factors and Mortality of Atrial Fibrillation in Breast Cancer: A SEER-Medicare Analysis.
    Eur Heart J. 2022 Jan 12. pii: 6505260. doi: 10.1093.
    >> Share

    December 2021

  231. Erratum to: Role of plakophilin-2 expression on exercise-related progression of arrhythmogenic right ventricular cardiomyopathy: a translational study.
    Eur Heart J. 2021 Dec 21. pii: 6472922. doi: 10.1093.
    >> Share

  232. NICHOLLS M
    Making connections to overcome arrhythmias.
    Eur Heart J. 2021;42:4878-4880.
    >> Share

  233. LABORI F, Persson J, Bonander C, Jood K, et al
    Cost-effectiveness analysis of left atrial appendage occlusion in patients with atrial fibrillation and contraindication to oral anticoagulation.
    Eur Heart J. 2021 Dec 17. pii: 6468857. doi: 10.1093.
    >> Share

  234. BRIGNOLE M, Pentimalli F, Palmisano P, Landolina M, et al
    Corrigendum to: AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial.
    Eur Heart J. 2021 Dec 8. pii: 6456446. doi: 10.1093.
    >> Share

  235. CREA F
    Management of arrhythmias: the increasing role of artificial intelligence, genetics and cardiac resyncronization.
    Eur Heart J. 2021;42:4703-4706.
    >> Share

  236. ATTIA ZI, Harmon DM, Behr ER, Friedman PA, et al
    Application of artificial intelligence to the electrocardiogram.
    Eur Heart J. 2021;42:4717-4730.
    >> Share

  237. HATALA R
    Rhythm control in asymptomatic 'early' atrial fibrillation: birth of a new paradigm?
    Eur Heart J. 2021 Dec 2. pii: 6448252. doi: 10.1093.
    >> Share

    November 2021
  238. BOR WL, Ten Berg JM
    Known or new atrial fibrillation in patients with acute coronary syndrome: what's the difference?
    Eur Heart J. 2021;42:4562-4564.
    >> Share

  239. AHLBERG G, Andreasen L, Ghouse J, Bertelsen L, et al
    Genome-wide association study identifies 18 novel loci associated with left atrial volume and function.
    Eur Heart J. 2021;42:4523-4534.
    >> Share

  240. CERRONE M, Marron-Linares GM, van Opbergen CJM, Costa S, et al
    Role of plakophilin-2 expression on exercise-related progression of arrhythmogenic right ventricular cardiomyopathy: a translational study.
    Eur Heart J. 2021 Nov 19. pii: 6431860. doi: 10.1093.
    >> Share

  241. MERINO JL
    Atrial fibrillation and breast cancer: Casual or causal relationship?
    Eur Heart J. 2021 Nov 14. pii: 6427544. doi: 10.1093.
    >> Share

  242. GUHA A, Fradley MG, Dent SF, Weintraub NL, et al
    Incidence, risk factors, and mortality of atrial fibrillation in breast cancer: a SEER-Medicare analysis.
    Eur Heart J. 2021 Nov 14. pii: 6427396. doi: 10.1093.
    >> Share

    October 2021
  243. HEIDBUCHEL H, Van Gelder IC, Desteghe L
    ESC and EHRA lead a path towards integrated care for multimorbid atrial fibrillation patients: the Horizon 2020 EHRA-PATHS project.
    Eur Heart J. 2021 Oct 25. pii: 6409895. doi: 10.1093.
    >> Share

  244. BRIGNOLE M, Pentimalli F, Palmisano P, Landolina M, et al
    Corrigendum to: AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial.
    Eur Heart J. 2021 Oct 16. pii: 6398359. doi: 10.1093.
    >> Share

  245. LUSCHER TF, Davies A, Beer JH, Valgimigli M, et al
    Towards personalized antithrombotic management with drugs and devices across the cardiovascular spectrum.
    Eur Heart J. 2021 Oct 8. pii: 6384672. doi: 10.1093.
    >> Share

  246. NAGARAJAN VD, Lee SL, Robertus JL, Nienaber CA, et al
    Artificial intelligence in the diagnosis and management of arrhythmias.
    Eur Heart J. 2021;42:3904-3916.
    >> Share

  247. NAUFFAL V, Marstrand P, Han L, Parikh VN, et al
    Worldwide differences in primary prevention implantable cardioverter defibrillator utilization and outcomes in hypertrophic cardiomyopathy.
    Eur Heart J. 2021;42:3932-3944.
    >> Share

  248. CREA F
    The growing role of artificial intelligence and of wearable devices in the management of arrhythmias.
    Eur Heart J. 2021;42:3889-3893.
    >> Share

  249. GARG L, Fradley MG
    QT prolongation and cancer therapeutics: a coming Tempest or Much Ado About Nothing?
    Eur Heart J. 2021;42:3929-3931.
    >> Share

  250. VAN DER WERF C, Lambiase PD
    Initiation and management of polymorphic ventricular tachycardia: history gone full circle.
    Eur Heart J. 2021;42:3976-3978.
    >> Share

  251. ROSSO R, Hochstadt A, Viskin D, Chorin E, et al
    Polymorphic ventricular tachycardia, ischaemic ventricular fibrillation, and torsade de pointes: importance of the QT and the coupling interval in the differential diagnosis.
    Eur Heart J. 2021;42:3965-3975.
    >> Share

  252. LINDE C
    Pace and ablate better than drugs in patients with heart failure and atrial fibrillation: lessons from the APAF-CRT mortality trial.
    Eur Heart J. 2021 Oct 6. pii: 6382271. doi: 10.1093.
    >> Share

    September 2021
  253. RUSSO AM
    Alcohol intake and risk of stroke in atrial fibrillation: the lesser the better, but this is not enough.
    Eur Heart J. 2021 Sep 30. pii: 6378270. doi: 10.1093.
    >> Share

  254. WALSH R, Adler A, Amin AS, Abiusi E, et al
    Evaluation of gene validity for CPVT and short QT syndrome in sudden arrhythmic death.
    Eur Heart J. 2021 Sep 24. pii: 6374783. doi: 10.1093.
    >> Share

  255. TINKER A
    Does knowledge of the mutation in hereditary long QT syndrome aid risk stratification?
    Eur Heart J. 2021 Sep 20. pii: 6372801. doi: 10.1093.
    >> Share

  256. CREA F
    The ESC Guidelines on cardiac pacing and resynchronization, and the many facets of atrial fibrillation.
    Eur Heart J. 2021;42:3411-3414.
    >> Share

  257. HINDRICKS G, Potpara T, Dagres N, Arbelo E, et al
    Corrigendum to: 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrill
    Eur Heart J. 2021 Sep 14. pii: 6370283. doi: 10.1093.
    >> Share

  258. GLIKSON M, Nielsen JC, Kronborg MB, Michowitz Y, et al
    2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy.
    Eur Heart J. 2021;42:3427-3520.
    >> Share

  259. LIN YN, Mesquita T, Sanchez L, Chen YH, et al
    Extracellular vesicles from immortalized cardiosphere-derived cells attenuate arrhythmogenic cardiomyopathy in desmoglein-2 mutant mice.
    Eur Heart J. 2021;42:3558-3571.
    >> Share

  260. SCHWARTZ PJ, Tan HL
    Long QT syndrome, artificial intelligence, and common sense.
    Eur Heart J. 2021 Sep 11. pii: 6368899. doi: 10.1093.
    >> Share

  261. SCHWARTZ PJ, Moreno C, Kotta MC, Pedrazzini M, et al
    Mutation location and IKs regulation in the arrhythmic risk of long QT syndrome type 1: the importance of the KCNQ1 S6 region.
    Eur Heart J. 2021 Sep 10. pii: 6368299. doi: 10.1093.
    >> Share

  262. NAUFFAL V, Marstrand P, Han L, Parikh VN, et al
    Worldwide differences in primary prevention implantable cardioverter defibrillator utilization and outcomes in hypertrophic cardiomyopathy.
    Eur Heart J. 2021 Sep 7. pii: 6365852. doi: 10.1093.
    >> Share

  263. STEINBERG C, Krahn AD
    Quinidine vs. ICD therapy in short-coupled ventricular fibrillation-is a randomized trial the next logical step?
    Eur Heart J. 2021 Sep 4. pii: 6364089. doi: 10.1093.
    >> Share

  264. BELHASSEN B
    Quinidine vs. ICD in patients with short-coupled idiopathic ventricular fibrillation: a call for a multicenter randomized trial.
    Eur Heart J. 2021 Sep 4. pii: 6364083. doi: 10.1093.
    >> Share

  265. PETERSEN JK, Haider Butt J, Yafasova A, Torp-Pedersen C, et al
    Incidence of ischaemic stroke and mortality in patients with acute coronary syndrome and first-time detected atrial fibrillation: a nationwide study.
    Eur Heart J. 2021 Sep 3. pii: 6363625. doi: 10.1093.
    >> Share

  266. BONNESEN MP, Frodi DM, Haugan KJ, Kronborg C, et al
    Day-to-day measurement of physical activity and risk of atrial fibrillation.
    Eur Heart J. 2021 Sep 2. pii: 6362464. doi: 10.1093.
    >> Share

  267. PRIFTI E, Fall A, Davogustto G, Pulini A, et al
    Deep learning analysis of electrocardiogram for risk prediction of drug-induced arrhythmias and diagnosis of long QT syndrome.
    Eur Heart J. 2021 Sep 1. pii: 6361017. doi: 10.1093.
    >> Share

  268. ELLIOTT AD, Middeldorp ME, Linz DK
    The ins and outs of physical activity monitoring: implications for atrial fibrillation management.
    Eur Heart J. 2021 Sep 1. pii: 6361015. doi: 10.1093.
    >> Share

    August 2021
  269. BRIGNOLE M, Pentimalli F, Palmisano P, Landolina M, et al
    AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial.
    Eur Heart J. 2021 Aug 28. pii: 6358077. doi: 10.1093.
    >> Share

  270. CURTAIN JP, Docherty KF, Jhund PS, Petrie MC, et al
    Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF.
    Eur Heart J. 2021 Aug 27. pii: 6358075. doi: 10.1093.
    >> Share

  271. WILLEMS S, Borof K, Brandes A, Breithardt G, et al
    Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial.
    Eur Heart J. 2021 Aug 27. pii: 6358078. doi: 10.1093.
    >> Share

  272. LIGHT PE
    Decoding the effects of SGLT2 inhibitors on cardiac arrhythmias in heart failure.
    Eur Heart J. 2021 Aug 27. pii: 6358226. doi: 10.1093.
    >> Share

  273. CHIANG PH, Hsu YC, Wei JC
    Methodological considerations when discussing the fracture risk of atrial fibrillation patients taking different drug.
    Eur Heart J. 2021 Aug 11. pii: 6348063. doi: 10.1093.
    >> Share

  274. HUANG HK, Tu YK, Loh CH
    Fracture risk associated with different oral anticoagulants in patients with atrial fibrillation: updated evidence from real-world observational studies and clinical trials.
    Eur Heart J. 2021 Aug 11. pii: 6348060. doi: 10.1093.
    >> Share

  275. WANG N, Sun Y, Zhang H, Wang B, et al
    Long-term night shift work is associated with the risk of atrial fibrillation and coronary heart disease.
    Eur Heart J. 2021 Aug 10. pii: 6347324. doi: 10.1093.
    >> Share

  276. SALEM JE, Nguyen LS, Moslehi JJ, Ederhy S, et al
    Anticancer drug-induced life-threatening ventricular arrhythmias: a World Health Organization pharmacovigilance study.
    Eur Heart J. 2021 Aug 9. pii: 6346756. doi: 10.1093.
    >> Share

  277. NICHOLLS M
    Reflections on EHRA 2021.
    Eur Heart J. 2021;42:2880-2881.
    >> Share

  278. RASMUSSEN PV, Hylek E
    Persistence with treatment in atrial fibrillation: still a pressing issue in the era of direct oral anticoagulants.
    Eur Heart J. 2021 Aug 4. pii: 6339772. doi: 10.1093.
    >> Share

  279. ROMITI GF, Corica B, Pipitone E, Vitolo M, et al
    Prevalence, management and impact of chronic obstructive pulmonary disease in atrial fibrillation: a systematic review and meta-analysis of 4,200,000 patients.
    Eur Heart J. 2021 Aug 1. pii: 6333297. doi: 10.1093.
    >> Share

  280. REIFFEL JA
    When two is not better than one: the amalgamation of atrial fibrillation and chronic obstructive pulmonary disease.
    Eur Heart J. 2021 Aug 1. pii: 6333293. doi: 10.1093.
    >> Share

    July 2021
  281. WILDE AAM, Wu CI
    Does function trump bioinformatics in Brugada syndrome-associated SCN5A mutation calling? Patients, computers, and patches.
    Eur Heart J. 2021;42:2864-2865.
    >> Share

  282. ISHIKAWA T, Kimoto H, Mishima H, Yamagata K, et al
    Functionally validated SCN5A variants allow interpretation of pathogenicity and prediction of lethal events in Brugada syndrome.
    Eur Heart J. 2021;42:2854-2863.
    >> Share

  283. ALHUMAID W, Yogasundaram H, Senaratne JM
    Slow bidirectional ventricular tachycardia as a manifestation of immune checkpoint inhibitor myocarditis.
    Eur Heart J. 2021;42:2868.
    >> Share

  284. GUASCH E, Nattel S
    Ageing, comorbidities, and the complex determinants of atrial fibrillation in athletes.
    Eur Heart J. 2021 Jul 23. pii: 6327053. doi: 10.1093.
    >> Share

  285. ADABAG S, Madjid M, Cheng A
    An attempt to reconcile the contrasting results of analyses on implantable cardioverter-defibrillator shocks during the pandemic.
    Eur Heart J. 2021 Jul 19. pii: 6323687. doi: 10.1093.
    >> Share


  286. Erratum to: Personalized anti-thrombotic management of patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1 - a statement of the ESC Working Group on Cardiovascular Pharmacotherapy and ESC Council on Stroke.
    Eur Heart J. 2021 Jul 16. pii: 6322394. doi: 10.1093.
    >> Share

  287. TOOROP MMA, Chen Q, Tichelaar VYIG, Cannegieter SC, et al
    Predictors, time course, and outcomes of persistence patterns in oral anticoagulation for non-valvular atrial fibrillation: a Dutch Nationwide Cohort Study.
    Eur Heart J. 2021 Jul 16. pii: 6322389. doi: 10.1093.
    >> Share

  288. BUNTING KV, Stanbury M, Tica O, Kotecha D, et al
    Transforming clinical research by involving and empowering patients- the RATE-AF randomized trial.
    Eur Heart J. 2021;42:2411-2414.
    >> Share

    June 2021

  289. Erratum to: Alcohol Consumption, Cardiac Biomarkers and Risk of Atrial Fibrillation and Adverse Outcomes.
    Eur Heart J. 2021 Jun 30. pii: 6311430. doi: 10.1093.
    >> Share

  290. VAN DER REE MH, Postema PG
    What's in a name? further classification of patients with apparent idiopathic ventricular fibrillation.
    Eur Heart J. 2021 Jun 21. pii: 6306957. doi: 10.1093.
    >> Share

  291. SCHNABEL RB, Fabritz L, Kirchhof P
    Mobile health for walking on the tightrope of optimal physical activity to reduce the risk of atrial fibrillation.
    Eur Heart J. 2021 Jun 20. pii: 6306826. doi: 10.1093.
    >> Share


  292. Corrigendum to: A huge atrial thrombus in a patient with bioprosthetic valve and atrial fibrillation: something went wrong with anticoagulation therapy.
    Eur Heart J. 2021 Jun 16. pii: 6300115. doi: 10.1093.
    >> Share

  293. VERSTRAELEN TE, van Lint FHM, Bosman LP, de Brouwer R, et al
    Prediction of ventricular arrhythmia in phospholamban p.Arg14del mutation carriers-reaching the frontiers of individual risk prediction.
    Eur Heart J. 2021 Jun 11. pii: 6296140. doi: 10.1093.
    >> Share

  294. LEE SR, Choi EK, Jung JH, Han KD, et al
    Lower risk of stroke after alcohol abstinence in patients with incident atrial fibrillation: a nationwide population-based cohort study.
    Eur Heart J. 2021 Jun 7. pii: 6294435. doi: 10.1093.
    >> Share

    May 2021
  295. KHURSHID S, Weng LC, Al-Alusi MA, Halford JL, et al
    Accelerometer-derived physical activity and risk of atrial fibrillation.
    Eur Heart J. 2021 May 25. pii: 6283622. doi: 10.1093.
    >> Share

  296. PARK S, Lee S, Kim Y, Lee Y, et al
    Atrial fibrillation and kidney function: a bidirectional Mendelian randomization study.
    Eur Heart J. 2021 May 23. pii: 6282432. doi: 10.1093.
    >> Share

  297. BENN M
    Atrial Fibrillation And Chronic Kidney Disease.
    Eur Heart J. 2021 May 23. pii: 6282434. doi: 10.1093.
    >> Share

  298. TOMSITS P, Clauss S, Kaab S
    Genetic insight into sick sinus syndrome. Is there a pill for it or how far are we on the translational road to personalized medicine?
    Eur Heart J. 2021;42:1972-1975.
    >> Share

  299. MARSTON NA, Han L, Olivotto I, Day SM, et al
    Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathy.
    Eur Heart J. 2021;42:1988-1996.
    >> Share

  300. THOROLFSDOTTIR RB, Sveinbjornsson G, Aegisdottir HM, Benonisdottir S, et al
    Genetic insight into sick sinus syndrome.
    Eur Heart J. 2021;42:1959-1971.
    >> Share

  301. THOROLFSDOTTIR RB, Sveinbjornsson G, Aegisdottir HM, Benonisdottir S, et al
    Genetic insight into sick sinus syndrome.
    Eur Heart J. 2021;42:1959-1971.
    >> Share

  302. STEINBERG C, Davies B, Mellor G, Tadros R, et al
    Short-coupled ventricular fibrillation represents a distinct phenotype among latent causes of unexplained cardiac arrest: a report from the CASPER registry.
    Eur Heart J. 2021 May 19. pii: 6278425. doi: 10.1093.
    >> Share

  303. CSENGERI D, Sprunker NA, Schnabel RB
    Alcohol and atrial fibrillation: dose matters, not so much the type.
    Eur Heart J. 2021 May 9. pii: 6272848. doi: 10.1093.
    >> Share

  304. MESSERLI FH, Dobner S
    Alcohol and atrial fibrillation: not all drinks are created equal.
    Eur Heart J. 2021 May 8. pii: 6272093. doi: 10.1093.
    >> Share

  305. KROHN-GRIMBERGHE M, Duerschmied D, Bode C
    What do we learn by repeating the ABC?
    Eur Heart J. 2021;42:1707-1709.
    >> Share

  306. GNECCHI M, Sala L, Schwartz PJ
    Precision Medicine and cardiac channelopathies: when dreams meet reality.
    Eur Heart J. 2021;42:1661-1675.
    >> Share

  307. DELISE P
    Risk stratification in Brugada syndrome: the challenge of the grey zone.
    Eur Heart J. 2021;42:1696-1697.
    >> Share

  308. PROBST V, Goronflot T, Anys S, Tixier R, et al
    Robustness and relevance of predictive score in sudden cardiac death for patients with Brugada syndrome.
    Eur Heart J. 2021;42:1687-1695.
    >> Share

  309. MINOIS D, Sellal JM, Magnin I, de Chillou C, et al
    Left ventricular diverticulum associated with two concealed atrioventricular accessory pathways.
    Eur Heart J. 2021;42:1714.
    >> Share

    April 2021
  310. GALIUTO L, Volpe M
    Cryoblation as first-line treatment of new-onset atrial fibrillation?
    Eur Heart J. 2021;42:1543-1544.
    >> Share

  311. SMOLDEREN KG, Burg MM
    A broken heart after child loss.
    Eur Heart J. 2021;42:1496-1498.
    >> Share

  312. BRIEGER D, Freedman B
    Decoding stroke risk scores in atrial fibrillation: still more work to do.
    Eur Heart J. 2021 Apr 6. pii: 6213361. doi: 10.1093/eurheartj/ehaa1111.
    >> Share

    March 2021
  313. EL-BATTRAWY I, Lang S, Zhou X, Akin I, et al
    Different genotypes of Brugada syndrome may present different clinical phenotypes: electrophysiology from bench to bedside.
    Eur Heart J. 2021;42:1270-1272.
    >> Share

  314. PAPPONE C, Ciconte G, Micaglio E, Monasky MM, et al
    Common modulators of Brugada syndrome phenotype do not affect SCN5A prognostic value.
    Eur Heart J. 2021;42:1273-1274.
    >> Share

  315. YOUNIS A, Goldenberg I
    Extending the MADIT-ICD benefit score to heterogenous heart failure populations.
    Eur Heart J. 2021 Mar 18. pii: 6177051. doi: 10.1093.
    >> Share

  316. POSTEMA PG, Walsh R, Bezzina CR
    Illuminating the path from genetics to clinical outcome in Brugada syndrome.
    Eur Heart J. 2021;42:1091-1093.
    >> Share

  317. BEHR ER, Ben-Haim Y, Ackerman MJ, Krahn AD, et al
    Brugada syndrome and reduced right ventricular outflow tract conduction reserve: a final common pathway?
    Eur Heart J. 2021;42:1073-1081.
    >> Share

  318. CICONTE G, Monasky MM, Santinelli V, Micaglio E, et al
    Brugada syndrome genetics is associated with phenotype severity.
    Eur Heart J. 2021;42:1082-1090.
    >> Share

  319. IRIART X, Metras A, Coiffic A, Thambo JB, et al
    Late device-related thrombus after left atrial appendage closure: never let your guard down.
    Eur Heart J. 2021;42:1050.
    >> Share

    February 2021
  320. SAWANO S, Nakayama A, Morita H, Komuro I, et al
    Rathke's cleft cyst induced cardiac arrest.
    Eur Heart J. 2021;42:714.
    >> Share

  321. CRIJNS HJGM, Prinzen F, Lambiase PD, Sanders P, et al
    The year in cardiovascular medicine 2020: arrhythmias.
    Eur Heart J. 2021;42:499-507.
    >> Share

  322. SCHNEEWEIS C, Ahrens I, Saygili E, Steven D, et al
    Cardiac involvement in sarcoidosis and necessary ventricular tachycardia ablation.
    Eur Heart J. 2021;42:544.
    >> Share

    January 2021
  323. KITE TA, Gershlick AH
    High-risk NSTE-ACS: high time for robust data.
    Eur Heart J. 2021;42:352.
    >> Share

  324. HAMILTON GW, Lim HS
    Ventricular tachycardia vs. supraventricular tachycardia with aberrancy.
    Eur Heart J. 2021;42:133.
    >> Share

    December 2020
  325. CAO D, Chandiramani R, Chiarito M, Claessen BE, et al
    Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey.
    Eur Heart J. 2020 Dec 26. pii: 6050475. doi: 10.1093.
    >> Share

  326. WILDE AAM, Lodder EM
    Biomarkers in inherited arrhythmias: necessity for validation and collaboration.
    Eur Heart J. 2020;41:4523-4524.
    >> Share

  327. HAMILTON RM, Chatterjee D, Saguner AM
    Biomarkers in inherited arrhythmias: opportunities for validation and collaboration.
    Eur Heart J. 2020;41:4521-4522.
    >> Share

    November 2020
  328. VERHAMME P, Budts W, Van de Werf F
    Non-vitamin K oral anticoagulants in adults with congenital heart disease: quod non?
    Eur Heart J. 2020;41:4178-4180.
    >> Share

    April 2020
  329. HILDICK-SMITH D, Landmesser U, Camm AJ, Diener HC, et al
    Left atrial appendage occlusion with the Amplatzer Amulet device: full results of the prospective global observational study.
    Eur Heart J. 2020 Apr 3. pii: 5815608. doi: 10.1093.
    >> Share

    January 2020
  330. FAROUX L, Chen S, Muntane-Carol G, Regueiro A, et al
    Clinical impact of conduction disturbances in transcatheter aortic valve replacement recipients: a systematic review and meta-analysis.
    Eur Heart J. 2020 Jan 3. pii: 5695667. doi: 10.1093.
    >> Share

    December 2019
  331. LANCINI D, Shetty R
    Tension pneumothorax: a Brugada phenocopy and ST-elevation myocardial infarction mimic.
    Eur Heart J. 2019 Dec 28. pii: 5688935. doi: 10.1093.
    >> Share

  332. KALLA M, Hao G, Tapoulal N, Tomek J, et al
    The cardiac sympathetic co-transmitter neuropeptide Y is pro-arrhythmic following ST-elevation myocardial infarction despite beta-blockade.
    Eur Heart J. 2019 Dec 13. pii: 5675548. doi: 10.1093.
    >> Share

    August 2019
  333. PACKER M
    What causes sudden death in patients with chronic heart failure and a reduced ejection fraction?
    Eur Heart J. 2019 Aug 7. pii: 5544750. doi: 10.1093.
    >> Share

    June 2019
  334. REDDY YNV, Borlaug BA, O'Connor CM, Gersh BJ, et al
    Novel approaches to the management of chronic systolic heart failure: future directions and unanswered questions.
    Eur Heart J. 2019 Jun 14. pii: 5519089. doi: 10.1093.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016